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Abstract
Background: Malaria that is caused by Plasmodium vivax is the most widely distributed human malaria. Its recent
resurgence in many parts of the world, including the Republic of Korea (ROK), emphasizes the importance of
improved access to the early and accurate detection of P. vivax to reduce disease burden. In this study, a rapid and
efficient loop-mediated isothermal amplification (LAMP)-based method was developed and validated using blood
samples from malaria-suspected patients.
Method: A LAMP assay targeting the α-tubulin gene for the detection of P. vivax was developed with six primers
that recognize different regions of the target gene. The diagnostic performance of the α-tubulin LAMP assay was
compared to three other tests: microscopic examinations, rapid diagnostic tests (RDTs), and nested polymerase
chain reactions (PCRs) using 177 whole blood specimens obtained from ROK military personnel from May to
December 2011.
Results: The α-tubulin LAMP assay was highly sensitive with a detection limit of 100 copies of P. vivax α-tubulin
gene per reaction within 50 min. It specifically amplified the target gene only from P. vivax. Validation of the
α-tubulin LAMP assay showed that the assay had the highest sensitivity (P < 0.001 versus microscopy; P = 0.0023
versus RDT) when nested PCR was used as the gold standard and better agreement (concordance: 94.9%, kappa
value: 0.865) with nested PCR than RDT and microscopy. A Receiver Operation Characteristics analysis showed that
the diagnostic accuracy of the α-tubulin LAMP assay for vivax malaria was higher (Area Under Curve = 0.908) than
RDT and microscopy.
Conclusion: This study showed that the P. vivax α-tubulin LAMP assay, which can be used to diagnose early
infections of vivax malaria, is an alternative molecular diagnostic tool and a point-of-care test that may help to
prevent transmission in endemic areas.
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Loop-mediated isothermal amplification
* Correspondence: ychong@knu.ac.kr
1Department of Parasitology and Tropical Medicine, Kyungpook National
University School of Medicine, 700-422 Daegu, Republic of Korea
Full list of author information is available at the end of the article
© 2014 Dinzouna-Boutamba et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of
the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public
Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this
article, unless otherwise stated.
Dinzouna-Boutamba et al. Malaria Journal 2014, 13:248
http://www.malariajournal.com/content/13/1/248Background
Plasmodium vivax, which is a causative agent of human
malaria, is the most widely distributed species, and 2.8
billion people are at risk for transmission in the world
[1]. Vivax malaria reemerged in 1993 in the Republic of
Korea (ROK or South Korea), and its incidence rapidly
increased to 4,142 by 2000. Plasmodium vivax malaria is
commonly believed to be clinically benign and self-
limiting [2,3]. However, accumulating lines of evidence
have shown that the impacts of P. vivax malaria with re-
spect to economic and social burdens in endemic re-
gions have been underestimated [4-6]. Moreover, the
resurgence of vivax malaria in many parts of the world,
including the ROK [7,8], emphasizes the importance of
improving access to reliable diagnostic methods that fa-
cilitate the early and accurate diagnosis of malaria,
which is urgently required to facilitate disease manage-
ment and control [9].
Microscopic examinations of Giemsa-stained thick and
thin blood films, which are considered the gold standard
for the diagnosis of malaria [10,11], are recommended by
the World Health Organization. Although this technique
is highly specific, its sensitivity for the detection of P.
vivax is lower than for Plasmodium falciparum due to
the low parasitaemia of P. vivax [12]. Furthermore, it is
time consuming, labour-intensive, and requires technical
expertise with respect to the interpretation of Giemsa-
stained blood smears. Immunochromatographic rapid
diagnostic tests (RDTs) that are based on the detection of
histidine-rich protein-2 and/or lactate dehydrogenase
[11,13] provide rapid and straightforward field tests for
the detection of P. vivax but are limited in terms of sensi-
tivity and specificity [14,15]. Accordingly, molecular diag-
nostic methods, such as polymerase chain reaction (PCR)
and nested PCR, have been developed and used to im-
prove P. vivax detection [16-21]. Although these assays
have been shown to be highly effective for diagnosing
malaria, they require laboratory equipment, trained
personnel, and have long turnaround times, which limit
their usefulness for routine diagnoses in the field [22].
Loop-mediated isothermal amplification (LAMP), which
is a relatively straightforward and sensitive technique that
is based on rapid DNA amplification under isothermal
conditions, was recently developed to remove the need
for sophisticated and expensive thermal cyclers [23].
LAMP involves the specific amplification of target DNA
by Bacillus stearothermophilus (Bst)D N Ap o l y m e r a s e ,
allowing strand displacement DNA synthesis with a set of
six oligonucleotides that recognize independent regions of
the target gene. The use of six oligonucleotides improves
the specificity and speed of the amplification and forms a
loop-structured amplicon, which produces a typical ladder-
pattern of multiple bands [24]. A positive reaction is easily
determined by eye as turbidity [25] or fluorescence by the
inclusion of fluorescent detection dyes, such as SYBR green
or hydroxynaphthol under UV light [26,27]. These features
allow LAMP assays to be used to detect many pathogenic
organisms, such as viruses, bacteria, fungi, parasites, and
vivax malaria parasites [28-31].
The present study was undertaken to develop an α-
tubulin targeting LAMP assay for the detection of P.
vivax and to validate the assay using whole blood from
suspected malaria patients. The sensitivity and specificity
of the devised P. vivax α-tubulin LAMP assay were de-
termined and compared with those of microscopy and
RDTs with 18S ribosomal RNA (rRNA)-based nested
PCR as gold standard. To validate the accuracies of the
α-tubulin targeting LAMP assay, the performances of
the tests examined were assessed using receiver operat-
ing characteristic (ROC) [32,33].
Methods
Samples
This study was conducted at Armed Forces Hospitals that
treat soldiers stationed near the DMZ, which separates
the ROK from the Democratic People’s Republic of Korea
(DPRK or North Korea), in the northern part of the
Gyeonggi-do Province, in the northwest region of the
ROK (between 37°–38° latitude and 127°–128° longitude).
This is a high-risk area for malaria and where only P.
vivax is transmitted [34]. All enrolled soldiers had no his-
tory of travel to malaria-endemic areas and had never re-
ceived a blood transfusion. Whole blood samples were
collected by sequential sampling from 177 male ROK sol-
diers, who provided written informed consent, among all
189 ROK male soldiers who had been admitted to the
Armed Forces Hospitals (from May to December 2011)
with febrile illness (temperature≥38°C) and were clinically
suspected to have malaria. To detect P. vivax, approxi-
mately 1 mL of blood was collected by venipuncture into a
vacutainer tube (Becton Dickinson, Franklin Lakes, NJ,
USA) containing ethylenediaminetetraacetic acid (EDTA).
Samples were transported on ice within 4 h to a laboratory
(Department of Parasitology and Tropical Medicine,
Kyungpook National University School of Medicine,
Daegu, ROK) where they were stored at −70°C. As is re-
quired by the Declaration of Helsinki, donor confidenti-
ality was maintained throughout, and the study was
approved by the Ethics Committee of the Armed Forces
Medical Command (AFMC-13-IRB-053, July 2011).
Microscopic examination and rapid diagnostic tests
These samples were assayed using standard diagnostic
procedures, including direct microscopic examination of
Giemsa-stained thick and thin blood films and RDT.
The 177 blood samples from malaria-suspected patients
were first examined with RDT and microscopy at the
Armed Forces Hospitals. The results for microscopy and
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each sample was blinded and transported to the labora-
tory (Department of Parasitology and Tropical Medicine,
Kyungpook National University School of Medicine,
Daegu) for further microscopic examination. A slide was
considered negative if no asexual stages of Plasmodium
spp. were found during examination of 100 fields. Para-
site densities were assessed by counting against 200 leu-
cocytes, and converting to parasites per microliter,
assuming a standard leucocyte count of 8,000/μL. The
immunochromatographic RDT (SD malaria Ag Pf/Pan,
Standard Diagnostic, Inc., Hagal-Dong, Korea) detects
the parasite antigen Plasmodium falciparum Histidine-
rich protein-2 (PfHRP-2) specific to P. falciparum in one
capture site and pan-Plasmodium lactate dehydrogenase
(pan-pLDH) for all four Plasmodium species, in a separ-
ate capture line.
α-tubulin LAMP assay
The P. vivax-specific LAMP primers were designed
based on previously described using the Primer Explorer
program [23,35] (Figure 1). The α-tubulin sequences of
P. vivax
P. falciparum
P. knowlesi
P. vivax
P. falciparum
P. knowlesi
P. vivax
P. falciparum
P. knowlesi
P. vivax
P. falciparum
P. knowlesi
P. vivax
P. falciparum
P. knowlesi
F3 F2
LF
B3 B2
LB B1c
F1c
A
AatII 
B
Primer Sequence  (5'- 3') 
F3 GTGGACGAAGTGCGAACG
B3 CAGACCACTTCCTGTTCCTC 
FIP (F1c-F2)  TGGCGAAGTTGTTTGCTGCGTCTACCGCCAGCTGTTTCAC 
BIP (B1c-B2)  TCGAGTGAGAAAGTTGGCGGACACCCACGGCATTGAACATG 
LF CCGGAGATTAGCTGCTCTGG 
LB AATTGCACAGGGCTTCAAGG 
Figure 1 Primer design for α-tubulin loop-mediated isothermal amplification (LAMP) assay for the detection of Plasmodium vivax. (A)
The primers were selected based on a nucleotide sequence alignment of the target region of α-tubulin gene from P. vivax, P. falciparum [GenBank
accession no. XM_001351490] and Plasmodium knowlesi [GenBank accession no. XM_002258237] using ClustalW software. Black boxes and bold
fonts indicate identical and conserved nucleotides, respectively. The locations of the primer recognition sites are indicated by arrows with the
primer names. The black arrowhead indicates the AatII cleavage site. F3, forward outer primer; B3, backward outer primer; FIP, forward inner primer;
BIP, backward inner primer; LF, loop forward primer; and LB, loop backward primer. (B) Sequences of the α-tubulin LAMP primers.
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from GenBank [P. vivax, GenBank accession no. XM_
001615073]. The P. vivax-specific α-tubulin LAMP pri-
mer set consisted of F3 (forward outer primer), B3
(backward outer primer), FIP (forward inner primer),
BIP (backward inner primer), LF (loop forward primer),
and LB (loop backward primer). LAMP was performed
for 90 min at 64°C in a 25-μL mixture containing 40
pmol each of FIP and BIP, 5 pmol each of F3 and B3, 20
pmol each of LF and LB, 1.4 mM deoxynucleoside tri-
phosphates, 0.8 M betaine, 1 μLo fBst DNA polymer-
ase (New England Biolabs, Ipswich, MA, USA) in
2.5 μLo fb u f f e r( 2 0m MT r i s –HCl, pH 8.8; 10 mM
KCl; 10 mM (NH4)2SO4;8m MM g S O 4; and 0.1%
Tween 20), and 1 μL of the plasmid containing the α-
tubulin gene fragment or genomic DNA from the whole
blood of malaria-suspected patients in a Loopamp real-
time turbidimeter (Realoop-30; Eiken Chemical Co.,
Ltd., Tokyo, Japan). After the LAMP assay, the reactions
were inactivated for 2 min at 80°C and then evaluated
by electrophoresis in an agarose gel (2.0%) or visualized
by a fluorescence detection reagent (FD; Eiken Chemical
Co., Ltd.) under UV light. The α-tubulin LAMP using
DNA from patients was performed in duplicate. Results
from the LAMP assay were independently recorded
using the UV lamp in real-time turbidimeter (Eiken
Chemical Co., Ltd.) by two investigators who were
blinded to the identity of the samples (Table 1 and
Table 2). If the results of the duplicate reactions were
discrepant, a third amplification and detection were per-
formed to resolve the discrepancy. After scoring the re-
sults of fluorescence detection, all the LAMP products
were electrophoresed on a 2% agarose gels for detection
of LAMP amplification. The results from gel electro-
phoresis were consistent with those from fluorescence
detection.
Analytical sensitivity and specificity of the α-tubulin
LAMP assay
The α-tubulin gene was amplified by PCR from P. vivax
with the F3 and B3 primers listed in Figure 1. The PCR
products were purified with a Qiaquick gel extraction kit
(QIAGEN, Inc., Valencia, CA, USA), and the eluted PCR
products were cloned into a pGEM-T easy vector (Pro-
mega Corporation, Madison, WI, USA). The amplified
DNA fragments were completely sequenced (Solgent Co.,
Ltd. Daejon, Korea) and confirmed to be identical to the
sequence of the α-tubulin gene from the P. vivax Sal-1
strain. The concentrations of plasmid DNA were mea-
sured with a NanoDrop ND-1000 spectrophotometer
(NanoDrop Products, Thermo Scientific Instruments,
Inc., Wilmington, DE, USA), and the corresponding copy
numbers were calculated. The plasmid containing the α-
tubulin gene fragment was diluted with TE buffer
(10 mM Tris–HCl, 1 mM EDTA) to final concentrations
of 1, 10, 10
2,1 0
3,o r1 0
4 copies of the gene per reaction.
The specificities of the LAMP assays were evaluated with
genomic DNA from P. falciparum 3D7, P. vivax Sal-1,
Plasmodium malariae Uganda I/CDC, Plasmodium ovale
curtisi, Plasmodium ovale wallikeri, Plasmodium know-
lesi H strain, Toxoplasma gondii RH, Cryptosporidium
parvum Iowa, and Babesia microti Munich strains. The
DNAs of the Entamoeba histolytica HM1:IMSS and
Giardia lamblia WB strains were kindly provided by
Dr. Myeong Heon Shin and Dr. Soon-Jung Park (Yonsei
University College of Medicine, Seoul, Korea).
Genomic DNA extraction from whole blood and
nested PCR
The DNAs were prepared from 100 μL of whole blood
with DNeasy tissue kits (QIAGEN, Inc.). One microlitre
of extracted DNA that was dissolved in 20 μL of double-
distilled water was used as a template for the nested PCR
and LAMP assay. On the other hand, heat-treated lysates
of whole blood samples were prepared as previously de-
scribed with minor modification [36,37]. Briefly, 1 ml of
ice-cold 5 mM sodium phosphate buffer (pH 8.0) was
added to 20 μl of whole blood sample, vortexed, and cen-
trifuged at 12,000×g for 5 min. The collected pellet was
washed two times with 5 mM sodium phosphate buffer
(pH 8.0), dissolved with 100 μl of distilled water, and
boiled for 10 min. The samples were centrifuged again at
12,000×g for 2 min, and the supernatants were col-
lected. Four microliter aliquots of the supernatants col-
lected were used as templates for LAMP. The nested
PCR based on the 18S rDNA gene was performed as pre-
viously described [16] in triplicate with TaKaRa LA Taq
polymerase (Takara Bio Inc., Shiga, Japan) in a reaction
volume of 20 μL with a thermal cycler (Perkin Elmer
Cetus, PerkinElmer Inc., Waltham, MA, USA). Two primer
sets for 18S rDNA gene, the universal primer (P1, 5′-AC
Table 1 Comparison of the results obtained from the four
diagnostic methods
Diagnostic test results No. of
cases
(%)
Microscopy RDT Nested PCR α-tubulin LAMP
+++ + 96 (54.2)
– ++ + 23 (13.0)
––++ 5 (2.8)
––++ 4 (2.3)
– + – + 8 (3.4)
– + –– 10 (5.6)
––– + 1 (0.6)
––– – 30 (16.9)
Total 177
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AAGACTTTGATTTCTCAT-3′)a n dt h eP. vivax specific
primer (P1, 5′-ACGATCAGATACCGTCGTA ATCTT-3′;
V1, 5′-CAATCTAAGAATAAACTCCGA AG AGAAA-3′)
that generated a 100-bp product, were employed per re-
action. The primer sets that were used had The PCR
products from each reaction were confirmed by DNA
sequencing (Solgent Co., Ltd.). The amplified products
were visualized on 1.5% agarose gels, stained with eth-
idium bromide, observed with a UV transilluminator, and
independently recorded by two experienced investigators
blinded against the other methods.
Statistical analysis
The test sensitivities and specificities were determined
using nested PCR as gold standard. The percentage sen-
sitivities and specificities with 95% confidence intervals
(95% CIs) were calculated with MedCalc, version 7.0
(MedCalc Software bvba, Ostend, Belgium). Differences
in the sensitivities and specificities were compared with
McNemar’s normal approximation test with SAS 9.3
(SAS Institute, Inc., Cary, NC, USA). Differences be-
tween the areas under the receiver operating characteris-
tic (AUC) were compared with a multiple logistic
regression model and SAS 9.3 (SAS Institute, Inc.). The
degree of agreement was determined using Kappa statis-
tics in SAS 9.3 (SAS Institute Inc.). Statistical signifi-
cance was accepted for p values less than 0.001.
Results
Optimization of the P. vivax α-tubulin LAMP assay
conditions
To develop a LAMP assay for the detection of P. vivax,a
set of six primers targeting the α-tubulin gene was de-
signed (Figure 1). The targeting region of the α-tubulin
DNA in this LAMP assay showed relatively low sequence
identity among Plasmodium spp. (P. knowlesi [GenBank
accession no. XM_002258237]: 84.0% nucleotide identity;
P. falciparum, [GenBank accession no. XM_001351490]:
77.6% nucleotide identity)(Figure 1A). The optimal
temperature and time for the LAMP reaction were
determined with a cloned α-tubulin gene fragment (10
6
copies per reaction) under isothermal conditions at tem-
peratures of 60°C to 65°C for 120 min by monitoring tur-
bidity. Although amplification targeting of the P. vivax
α-tubulin gene was detected at all of the temperatures
tested, a threshold value of absorbance (0.1) from the
LAMP assay was reached most quickly at 64°C (data not
shown). No nonspecific amplification was detected in
the negative control (plasmid containing no insert) after
at least 120 min of incubation. Thus, the subsequent
LAMP reactions were conducted at 64°C for 90 min.
Analytical sensitivity and specificity of the P. vivax
α-tubulin LAMP assay
To assess the sensitivity of the α-tubulin LAMP assay,
the LAMP assay was conducted with serially diluted
plasmid DNAs containing the α-tubulin gene to the
equivalent of 10
5 to 1 copy per reaction. The LAMP
procedure amplified the targeted region at each dilution
from the highest copy numbers (10
5 copies per reaction)
(Figure 2B) to as little as 100 copies of P. vivax α-
tubulin gene per reaction (linear regression coefficient
R
2 =0.9579), which reached the threshold value of ab-
sorbance (0.1) within 50 min (Figure 2A and B). The
specificity of the P. vivax α-tubulin LAMP assay was
evaluated with the genomic DNA of five known malaria-
associated species (P. falciparum, P. malariae, P. ovale
curtisi, P. ovale wallikeri, P. knowlesi) and seven patho-
genic but malaria-unrelated species, three belonging to
the phylum Apicomplexa (Babesia microti, Toxoplasma
gondii, and Cryptosporidium parvum) and four proto-
zoan parasites (Entamoeba histolytica, Giardia lamblia,
Trichomonas vaginalis, and Acanthamoeba castellanii).
As shown in Figure 2C, a typical ladder pattern of the
amplified LAMP products with agarose gel electrophor-
esis was only observed for the P. vivax genomic DNA.
The P. vivax α-tubulin LAMP assay showed no detect-
able amplification of the other DNAs, including the
malaria-negative human DNA controls (Figure 2C). The
amplified products of the positive reactions were also vi-
sualized with fluorescent detection reagents under UV
Table 2 Comparison of the results obtained with the diagnostic methods on the 177 whole blood samples
Assay No. positive No. negative Sensitivity
(95% CI
d)
Specificity
(95% CI)
PPV
a
(95% CI)
NPV
b
(95% CI)
% agreement with
nested PCR (Kappa)
AUC
c
(95% CI)
Microscopy 96 81 75.0
(66.8-81.7)
100
(91.1-100)
100
(95.3-100)
60.5
(49.6-70.4)
81.9
(0.624)
0.875
(0.817–0.920)
RDT 137 40 93.0
(87.9–96.4)
63.3
(49.2–75.3)
86.9
(80.1–91.6)
77.5
(62.2–87.8)
84.7
(0.596)
0.781
(0.713–0.840)
Nested PCR 128 49
α-tubulin LAMP 137 40 100
(96.4-100)
81.6
(68.3-90.2)
93.4
(87.8-96.6)
100
(89.3-100)
94.9
(0.865)
0.908
(0.856–0.946)
The sensitivities and specificities of the tests were determined using the nested PCR results as gold standard.
aPPV, positive predictive value,
bNPV, negative predictive value,
cAUC, area under the receiver operating characteristic curve,
dCI, confidence interval.
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the amplification by the α-tubulin LAMP assay, the
amplified LAMP products from the P. vivax genomic
DNA were digested with AatII (Figure 1, arrowhead)
and found to generate the expected 187- and 137-bp
fragments (Figure 2C, lane R).
Validation of the P. vivax α-tubulin LAMP assay
To validate the α-tubulin LAMP assays, the blood sam-
ples of 177 male ROK soldiers who were admitted with
febrile illness and who were suspected of having malaria
were subjected to α-tubulin LAMP and three available
methods, including microscopic examinations, immuno-
chromatographic RDTs and nested PCRs. To determine
the accuracy of the tests for diagnosis of P. vivax mal-
aria, nested PCR was used as a gold standard and the
sensitivity, specificity, positive predictive value (PPV),
and negative predictive value (NPV) were calculated for
each test. Of the 177 male ROK soldiers, 96 (54%), 137
(77%), 128 (72%), and 137 (77%) were positive for mi-
croscopy, RDT, nested PCR, and α-tubulin LAMP, re-
spectively. Microscopic examinations were positive for
96 specimens, resulting in a sensitivity of 75.0% (95% CI,
66.8%–81.7%) and a specificity of 100% (95% CI, 91.1%-
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Figure 2 Sensitivity and specificity of the P. vivax α-tubulin LAMP assay. (A) Sensitivity of the P. vivax α-tubulin LAMP assay. Serial 10-fold
dilutions of the α-tubulin DNA (10, 10
2,1 0
3, and 10
4 copies per reaction) were used for the LAMP assay, and the real-time amplification was
monitored by a measurement of absorbance. (B) Correlation between the threshold time and the copy number of the α-tubulin DNA in serially
diluted samples. The values on the y-axis are the threshold time (in min), which was defined as the time at which the threshold value of
absorbance (0.1) was reached. The results show the means and standard deviations of three separate experiments. A plasmid containing no insert
was used as a control. The LAMP products were visualized using (C) gel electrophoresis and (D) Loopamp® fluorescent detection reagent (FD).
Lane M, a 100-bp molecular weight marker; lane 1, P. falciparum; lane 2, Plasmodium ovale curtisi; lane 3, Plasmodium ovale wallikeri; lane 4,
Plasmodium malariae; lane 5, Plasmodium knowlesi; lane 6, P. vivax; lane 7, Babesia microti; lane 8, Toxoplasma gondii; lane 9, Cryptosporidium
parvum; lane 10, Entamoeba histolytica; lane 11, Giardia lamblia; lane 12, Trichomonas vaginalis; lane 13; Acanthamoeba castellanii; lane 14,
malaria-negative human DNA control; lane R, products of the AatII digestion of the LAMP product of α-tubulin.
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male patients was 1,263 [103–5,177]/μL. All 96 positive
specimens by microscopy were nested PCR positives.
Thirty-two of the 81 negative specimens by microscopy
were true positives by nested PCR and thus considered
false negatives (Table 1). The results obtained by RDT
were positive for 137 specimens, resulting in a sensitivity
of 93.0% (95% CI, 87.9%–96.4%) and a specificity of
63.3% (95% CI, 49.2%—75.3%) (Table 2). Eighteen of the
137 positive (18/137, 13.1%) by RDT were negative by
nested PCR for the detection of P. vivax and thus con-
sidered false positives. Nine of the 40 specimens (9/40,
22.5%) negative by RDT were true positive by nested
PCR and thus considered false negatives (Table 1). All
malaria-positive cases by RDT were identified as P. vivax
infections.
The sensitivity of the α-tubulin LAMP assays was
100% (95% CI, 96.4%–100%), and its specificity was
81.6% (95% CI, 68.3%–90.2%) (Table 2). Eight that were
positive by RDT but negative by nested PCR were posi-
tive by α-tubulin LAMP (Table 1). Of the 137 positives
by α-tubulin LAMP, 128 specimens (136/137, 99.3%)
were true positives, and thus 9 specimens were consid-
ered a false positive (Table 1). Ten of the 40 negative
specimens by α-tubulin LAMP assays were only positive
by RDT. On the other hand, α-tubulin LAMP assay con-
ducted using heat-treated lysates produced the same re-
sults as those obtained using a commercial kit (DNeasy
tissue kit) (data not shown). When nested PCR was used
as the gold standard, the α-tubulin LAMP assays had
the highest diagnostic sensitivity (P<0.001 vs. micros-
copy; P= 0.0023 vs. RDT) and better agreement (con-
cordance: 94.9%, kappa value: 0.865) with nested PCR
than RDT and microscopy (Table 2). To compare the
diagnostic accuracies of microscopy, RDT, and α-tubulin
LAMP assays for the detection of P. vivax, the diagnos-
tic accuracies were assessed by performing ROC analyses
and measuring the AUCs. Among these three diagnostic
tests when nested PCR was used as the gold standard,
the α-tubulin LAMP assay had the highest AUC (0.908)
(P =0.4272 vs. microscopy; P =0.0104 vs. RDT) among
the three tests.
Discussion
The resurgence of vivax malaria in many parts of the
world emphasizes the need for a rapid, sensitive, and in-
expensive diagnostic method. Furthermore, it needs to
be easily performed and to produce readily interpretable
results in the field of an endemic area. As one of the
diagnostic methods of vivax malaria, microscopic exami-
nations of blood samples are still widely used in many
malaria-endemic areas, including the ROK. As shown in
Table 2, microscopic examinations had the lowest sensi-
tivity (75.0%) among the four tests in this study.
Furthermore, the requirement of well-trained experts
and the long turnaround time limit its usefulness in the
field. Due to its convenience, RDT is currently and
widely used as an alternative field diagnostic test. How-
ever, recent studies suggest that RDT had relatively
lower sensitivity and specificity for P. vivax than P. fal-
ciparum [14,15,38]. The RDT in this study had high sen-
sitivity relative to that of the microscopy, and had lower
specificity and negative predictive values compared to
those of α-tubulin LAMP assays by considering nested
PCR as gold standard (Table 2). To solve these prob-
lems, molecular diagnostic tests, nested PCRs, and
LAMP assays have been developed [11,39]. In particular,
P. vivax LAMP assays that are based on 18S rDNA,
mitochondrial DNA, and Pvr64 have recently been de-
veloped and validated for the diagnosis of malaria
[28-30,40-44]. The sensitivities of nested PCRs and
LAMP assays for P. falciparum malaria have been shown
to be comparable or higher than RDTs, respectively [45].
Thus, the aim of this study was to design and test the
utility of a novel set of P. vivax-specific LAMP primers
with different target DNA sequences in order to improve
diagnostic performance and validate them as an alterna-
tive molecular diagnostic test. Although the tubulin gene
of P. vivax is not species-specific, the β-tubulin gene se-
quence has previously been used successfully to amplify
P. knowlesi DNA with a LAMP assay [46]. The targeting
region of the α-tubulin DNA in this LAMP assay
showed relatively low sequence identity among Plasmo-
dium spp. and its use has resulted in no cross reactivity
with the other malaria species examined.
In the present study, the diagnostic performance of α-
tubulin LAMP assays were compared to three currently
available tests, including microscopic examinations,
RDT, and nested PCRs using 177 whole blood speci-
mens. When nested PCR was used as gold standard, 128
(72.3%) of the 177 specimens were positive for vivax
malaria. PCR is still the most sensitive and specific
method for vivax malaria among all of the currently
available tests [47]. However, expensive laboratory equip-
ment, the need for a trained specialist, and time-
consuming post-PCR procedures, such as agarose gel
electrophoresis, limit the usefulness of nested PCR in
the field when diagnostic equipment is minimal. How-
ever, a LAMP assay does not require a thermal cycler
and can be performed with minimal laboratory facilities,
such as a heating block or a water bath, and its end
points can be determined by turbidity or color develop-
ment by eye. Furthermore, the straightforward sample
preparation for molecular diagnosis reduces the risk of
cross-contamination, and thus the risks posed by false-
positive results. LAMP assays that are based merely on
heat-treated blood have previously been found to be as
efficient at detecting malaria parasites as DNA that is
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results of α-tubulin LAMP assay based on heat-treated
samples were consistent with those of the LAMP assay
using a commercial kit. Thus, the devised P. vivax
LAMP assay could eliminate the need for DNA extrac-
tion without compromising sensitivity and reduce the
time required to reach a diagnosis. The α-tubulin LAMP
assay had the higher diagnostic accuracy (AUC=0.908)
than microscopy and RDT and showed better agreement
with nested PCR (Table 2) and thus can be used in the
diagnosis of early infections of vivax malaria as an alter-
native molecular diagnostic tool.
In endemic countries, including the ROK, vivax mal-
aria is also transmitted by the transfusion of infected
blood products [49,50], and, as yet, no reliable approved
laboratory test is available for the screening of donated
blood. Although the LAMP assay was applied to whole
blood samples of patients suspected to be infected, the
LAMP assay devised here could also be used for blood
screening for P. vivax. Furthermore, individuals with low
parasite density can provide reservoirs for transmission,
and thus an early and accurate diagnostic tool like the
α-tubulin LAMP assay may help to prevent transmission
in endemic areas.
Conclusion
This study describes about the development and valid-
ation of a LAMP assay for the detection of P. vivax
DNA in clinical blood samples. In addition, the P. vivax
α-tubulin LAMP assay developed here can be used to
diagnose early infections of vivax malaria, is an alterna-
tive molecular diagnostic tool and a point-of-care test
that may help to prevent transmission in endemic areas.
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